BIOGEN INC.'s Net Worth
$156 Million
Who is BIOGEN INC.?
BIOGEN INC. has an estimated net worth of $156 Million. This is based on reported shares across multiple companies, which include Sage Therapeutics, Inc., Denali Therapeutics Inc., SANGAMO THERAPEUTICS, INC, Bioverativ Inc., SUNESIS PHARMACEUTICALS INC, TARGETED GENETICS CORP /WA/, and REATA PHARMACEUTICALS INC.
SEC CIK
BIOGEN INC.'s CIK is 0000875045
Past Insider Trading and Trends
2005 was BIOGEN INC.'s most active year for acquiring shares with 3 total transactions. BIOGEN INC.'s most active month to acquire stocks was the month of August. 2005 was BIOGEN INC.'s most active year for disposing of shares, totalling 106 transactions. BIOGEN INC.'s most active month to dispose stocks was the month of June. 2005 saw BIOGEN INC. paying a total of $5,000,002.00 for 2,912,022 shares, this is the most they've acquired in one year. In 2023 BIOGEN INC. cashed out on 6,000,000 shares for a total of $3,000,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sage Therapeutics, Inc. (SAGE) Snapshot price: $24.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $17.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.4902
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.37% | -6.00M |
$0.50 | -$3,000,000.00 | 17.65M |
Sep 26
| |||
Form 4
| -2.07% | -500.00K |
$5.31 | -$2,657,240.00 | 23.65M |
Aug 29 - Aug 30
| |||
Form 4
| -0.01% | -2.76K |
$8.51 | -$23,521.92 | 24.15M |
Dec 28
| |||
Form 4
| -0.34% | -81.79K |
$8.55 | -$699,666.43 | 24.16M |
Dec 23 - Dec 27
| |||
Form 4
| -0.10% | -23.66K |
$8.56 | -$202,541.43 | 24.24M |
Dec 9
| |||
Form 4
| -0.52% | -127.99K |
$8.59 | -$1,099,264.81 | 24.26M |
Dec 7 - Dec 8
| |||
Form 4
| -0.01% | -2.60K |
$8.51 | -$22,166.04 | 24.39M |
Dec 1 - Dec 2
| |||
Form 4
| -0.12% | -28.88K |
$8.60 | -$248,434.17 | 24.39M |
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bioverativ Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -107.98M |
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.5601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.91M |
$7.00 | $5,000,002.00 | 2.91M |
Sep 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||